Guest guest Posted March 29, 2005 Report Share Posted March 29, 2005 Duramater, I don't think your questions are rudimentary, when compared to the state of the science. What's his face has misled many people about that by making unqualified, declarative statements and implying they are scientific in nature. So even people who don't buy what he's saying often get mistaken impressions of how much is currently known. I think your question about total T cell populations vs the ratio of Type 1 to Type 2 cells is very appropriate, I've read a squillion abstracts relating to this and I don't see much of a consensus. For a long time I avoided that whole discussion, because it seemed like such a murk. But then I kept coming across Lyme research that made it seem potentially very signficiant. Because the outer surface proteins on Bb spirochetes 'force' naive T-cells into the Th1 phenotype. This is not a universal behavior for bacterial pathogens. It seems that Type 2 cells are needed to form effective antibodies. To me, and to some researchers, this suggests that forcing Type 1 cells to develop would protect spirochetes. Yet Bb also locates intracellularly. An inflammatory response is presumably needed to force antibodies or antibiotic medications deep into the tissue. So whadda we do? Bear in mind, I don't even 'know' that I'm stating a real dilemma. There are researchers who describe it in these terms, but's that's about all I'm sure of. > > [in part]: > " IMO, here is the progression: > > Acute infection--> chronic/occult infection -> chronic inflammation --> > symptoms present as specific disorders depending on tissue type > (genetics, host-pathogen relationship) ---> secondary symptoms emerge > over time- allergies, GI problems, chemical and food sensitivities etc. " > > I absolutely concur about your hypothesized progression, albeit not > from a scientific place but rather an experiential position. > > What I'm particularly curious about is the Th1/Th2 relationship with > such a progression. I feel pretty confident in saying that in the > latest stage you hypothesize (allergies, chem & food sensitivities) > there is an over-regulation of Th2. But do we think there is a > concommitent up-regulation in Th1 (as hypothesized by whats his face)? > Or what is going on with Th1 if anything? From whence does the > inflammation arise? > > And being new to the literature on Th1/Th2, please SOMEONE correct my > rudimentary knowledge if its wrong... My understanding is that as one > tries to, say, downregulate Th1, T cells are shifted to Th2. So (A) > can one have too much Th1 AND Th2? (seems like you can if just too much > T cells are being generated in general) and ( lets say both are being > over-done. If one tries to tamp down Th1 (in the context of too high > Th1 & Th2), will that shift it over to EVEN MORE Th2???? > > Lastly, what happens to folks taking benicar/mino if it really does > tamp down Th1 cytokines but they already have too much Th2? Do Th2- > related symptoms get even worse? > > Again, apologies for the rudimentary nature of these questions, but I'm > just starting to work on my understanding of these areas involving > Th1/Th2 & cytokines. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.